Company Filing History:
1 out of 52 
1 out of 44 
Years Active: 2010
Title: Anja Mølhart Høg: Innovator in Oligomeric Compounds
Introduction
Anja Mølhart Høg is a notable inventor based in Vium, Denmark. He has made significant contributions to the field of biotechnology, particularly in the modulation of hypoxia-inducible factor-1α (HIF-1α) expression. His work has implications for the treatment of various diseases, including cancer and pre-eclampsia.
Latest Patents
Anja Mølhart Høg holds a patent for "Oligomeric compounds for the modulation HIF-1α expression." This patent involves oligonucleotides directed against the HIF-1α gene, which are designed to modulate the expression of HIF-1α. The compositions include antisense oligonucleotides targeted to nucleic acids encoding HIF-1α. The methods outlined in the patent provide innovative approaches for treating diseases associated with HIF-1α.
Career Highlights
Throughout his career, Anja Mølhart Høg has worked with prominent companies in the pharmaceutical industry. He has been associated with Enzon Pharmaceuticals, Inc. and Santaris Pharma A/S. His experience in these organizations has contributed to his expertise in developing therapeutic solutions.
Collaborations
Anja has collaborated with notable colleagues, including Charlotte Albæk Thrue and Paul E G Kristjansen. These partnerships have enhanced his research and development efforts in the field of biotechnology.
Conclusion
Anja Mølhart Høg is a distinguished inventor whose work in oligomeric compounds has the potential to advance medical treatments for serious health conditions. His contributions to the field are noteworthy and reflect his commitment to innovation.